Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.490
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
2.480
-0.010 (-0.40%)
After-hours: Dec 5, 2025, 6:37 PM EST
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $955.64 million as of December 5, 2025. Its market cap has increased by 23.13% in one year.
Market Cap
955.64M
Enterprise Value
179.09M
1-Year Change
23.13%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $955.64M, a decrease of -16.03%. That is a compound annual growth rate of -2.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 953.40M | 23.47% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |